Ruthvik Malladi, PharmD
Director, Medical Affairs
Ruthvik Malladi, PharmD, serves as Director, Medical Affairs at Hemab. He brings over seven years of biotech experience with a strong focus on rare diseases. Most recently, Ruthvik worked at Blueprint Medicines in field roles in both Commercial and Medical Affairs. Prior to that, Ruthvik worked at Alnylam Pharmaceuticals in various capacities, from scientific communications to diagnostics. Ruthvik supported the launch of five medicines and aims to advance more treatments for patients. Ruthvik holds a Doctor of Pharmacy from Northeastern University.
Meet the Team
Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders
